A Single-center,Proof of Concept,Randomized,Controlled Parallel Group Clinical Trial of the Effects of Exenatide vs. a Long Acting Insulin Analog to Evaluate the Efficacy of Exenatide in Patients With Diabetic Neuropathy and Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2015
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine
- Indications Diabetic neuropathies; Type 2 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- 11 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Dec 2013 Planned end date changed from 1 Dec 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.